Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Therapy in Spinal Cord Injury Patients With Bacteriuria
NCT06559618Phase 1Recruiting
- Start
- Feb 2025
- Primary completion
- Sep 2027
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TAILOR phage cocktail in asymptomatic bacteriuria (ASB) (2 arms). Primary endpoint: Safety and Tolerability at 2 years. Started Feb 2025; status: recruiting.
02
Drugs
TAILOR phage cocktail
03
Conditions
asymptomatic bacteriuria (ASB)
Beyond the preview
Go deeper on NCT06559618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06559618.